Rational design of Ras prenyltransferase inhibitors as potential anticancer drugs

被引：11
|
作者：
Sebti, SM [1 ]
Hamilton, AD [1 ]
机构：
[1] UNIV PITTSBURGH,DEPT CHEM,PITTSBURGH,PA 15261
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 1996年 / 24卷 / 03期
关键词：
D O I：
10.1042/bst0240692
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：692 / 699
页数：8
相关论文
共 50 条
  • [1] Novel HDAC Inhibitors as Potential Anticancer Drugs
    Sanchez-Michael, Laura
    Quesada, Gabriela Torres
    Gutierrez, Denisse
    Varela-Ramirez, Armando
    Vijayalaxmi, S.
    Karki, Subhas
    Aguilera, Renato
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S210 - S210
  • [2] Rational Design of Proteasome Inhibitors as Antimalarial Drugs
    Le Chapelain, Camille
    Groll, Michael
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (22) : 6370 - 6372
  • [3] Rational design of polymerase inhibitors as antiviral drugs
    Oberg, Bo
    ANTIVIRAL RESEARCH, 2006, 71 (2-3) : 90 - 95
  • [4] From fragment to lead: High throughput crystallography and rational design to identify CDKs inhibitors as anticancer drugs
    Berdini, Valerio
    Boulstridge, John A.
    Carr, Maria G.
    Cross, David M.
    Davis, Deborah J.
    Devine, Lindsay A.
    Early, Tess
    Feltell, Ruth E.
    Figueroa, Eva
    Lewis, John
    O'Brien, Alistair
    O'Reilly, Marc
    Squires, Matt S.
    Saxty, Gordon
    Seavers, Lisa
    Smith, Donna M.
    Trewartha, Gary
    Walker, Margaret T.
    Woodhead, Andrew J.
    Woolford, Alison J.
    Wyatt, Paul G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 142 - 142
  • [5] RATIONAL DESIGN OF PEPTIDE-BASED INHIBITORS OF TRYPANOTHIONE REDUCTASE AS POTENTIAL ANTITRYPANOSOMAL DRUGS
    GARFORTH, J
    MCKIE, JH
    JAOUHARI, R
    BENSON, TJ
    FAIRLAMB, AH
    DOUGLAS, KT
    AMINO ACIDS, 1994, 6 (03) : 295 - 299
  • [6] AUTOLOGOUS CYSTEINE PEPTIDASE INHIBITORS AS POTENTIAL ANTICANCER DRUGS
    SIEWINSKI, M
    ANTI-CANCER DRUGS, 1993, 4 (01) : 97 - 99
  • [7] FoxM1 inhibitors as potential anticancer drugs
    Gartel, Andrei L.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (06) : 663 - 665
  • [8] In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
    Gagic, Zarko
    Ruzic, Dusan
    Djokovic, Nemanja
    Djikic, Teodora
    Nikolic, Katarina
    FRONTIERS IN CHEMISTRY, 2020, 7
  • [9] FARNESYL TRANSFERASE INHIBITORS (ANTI-RAS) - A NEW CLASS OF ANTICANCER DRUGS
    LEVY, R
    PRESSE MEDICALE, 1995, 24 (15): : 725 - 729
  • [10] Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs
    Thiry, Anne
    Supuran, Claudiu T.
    Masereel, Bernard
    Dogne, Jean-Michel
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (11) : 3051 - 3056
12345